Contribution: Industrial Research Assistance Program – Contributions to Firms
CanBiocin Inc
$150,000.00
Probiotic Mode of Action and Deliverability Improvements based on Market Feedback
EF 2025-26 · 2025-04-01
Résumé
CanBiocin develops non-medicating zootechnical feed additives to support animal health and wellness brands. These additives include species-specific probiotics, prebiotics, and postbiotic metabolites. Market insights highlight three key areas for development: elucidating probiotic mechanisms of action, refining protective microencapsulation, and expanding probiotic solutions for underserved markets. This project addresses these challenges, enhancing product efficacy, scientific validation, and market potential.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Edmonton|Edmonton, Alberta, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
877112425
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2026-03-31
Agreement Number
1029846
Agreement Start Date
2025-04-01
Agreement Title
Probiotic Mode of Action and Deliverability Improvements based on Market Feedback
Agreement Title (French)
Amélioration du mode d’action et de la livrabilité des probiotiques en fonction des commentaires du marché
Agreement Type
Contribution
Agreement Value
$150,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
CanBiocin develops non-medicating zootechnical feed additives to support animal health and wellness brands. These additives include species-specific probiotics, prebiotics, and postbiotic metabolites. Market insights highlight three key areas for development: elucidating probiotic mechanisms of action, refining protective microencapsulation, and expanding probiotic solutions for underserved markets. This project addresses these challenges, enhancing product efficacy, scientific validation, and market potential.
Description (French)
CanBiocin développe des additifs zootechniques non médicamenteux destinés à améliorer la santé et le mieux-être des animaux. Ces additifs comprennent des probiotiques, des prébiotiques et des métabolites postbiotiques propres à certaines espèces. Les données du marché mettent en évidence trois domaines clés de développement : élucider les mécanismes d’action des probiotiques, perfectionner la micro-encapsulation protectrice et élargir l’offre de solutions probiotiques pour les marchés mal desservis. Ce projet relève ces défis en améliorant l’efficacité des produits, leur validation scientifique et leur potentiel commercial.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Centre
Federal Riding (French)
Edmonton-Centre
Federal Riding Number
48014
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
877112425
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
CanBiocin Inc
Recipient Operating Name
CanBiocin
Recipient Postal Code
T5J 4P6
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2025-2026-Q1-1029846
